Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs)

NCT00254696 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT00254696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00254696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs)
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
March 31, 2005
Enrollment
710 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infection